Boothbay Fund Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.72M | Buy |
75,212
+38,768
| +106% | +$3.1M | 0.06% | 336 |
|
|
2025
Q4 | $3.47M | Buy |
36,444
+8,194
| +29% | +$803K | 0.05% | 415 |
|
|
2025
Q3 | $2.76M | Buy |
28,250
+25,854
| +1,079% | +$2.68M | 0.04% | 490 |
|
|
2025
Q2 | $257K | Sell |
2,396
-1,500
| -39% | -$152K | 0.01% | 1163 |
|
|
2025
Q1 | $393K | Sell |
3,896
-32,238
| -89% | -$3.25M | 0.01% | 955 |
|
|
2024
Q4 | $3.23M | Sell |
36,134
-68,182
| -65% | -$6M | 0.08% | 333 |
|
|
2024
Q3 | $8.74M | Buy |
104,316
+57,846
| +124% | +$4.56M | 0.2% | 125 |
|
|
2024
Q2 | $3.58M | Buy |
46,470
+11,974
| +35% | +$876K | 0.08% | 320 |
|
|
2024
Q1 | $2.36M | Buy |
34,496
+23,917
| +226% | +$1.54M | 0.05% | 445 |
|
|
2023
Q4 | $612K | Sell |
10,579
-107,937
| -91% | -$5.76M | 0.02% | 910 |
|
|
2023
Q3 | $6.26M | Sell |
118,516
-18,755
| -14% | -$984K | 0.15% | 156 |
|
|
2023
Q2 | $7.42M | Sell |
137,271
-60,241
| -30% | -$3.15M | 0.16% | 125 |
|
|
2023
Q1 | $9.88M | Sell |
197,512
-80,532
| -29% | -$3.8M | 0.2% | 81 |
|
|
2022
Q4 | $12.9M | Sell |
278,044
-151,350
| -35% | -$6.55M | 0.3% | 37 |
|
|
2022
Q3 | $16.6M | Buy |
429,394
+22,180
| +5% | +$890K | 0.42% | 18 |
|
|
2022
Q2 | $15.2M | Buy |
407,214
+174,581
| +75% | +$7.11M | 0.4% | 18 |
|
|
2022
Q1 | $10.3M | Buy |
232,633
+68,301
| +42% | +$2.96M | 0.24% | 58 |
|
|
2021
Q4 | $6.98M | Buy |
164,332
+30,785
| +23% | +$1.29M | 0.16% | 131 |
|
|
2021
Q3 | $5.79M | Buy |
133,547
+100,622
| +306% | +$4.45M | 0.16% | 130 |
|
|
2021
Q2 | $1.41M | Sell |
32,925
-7,283
| -18% | -$306K | 0.05% | 543 |
|
|
2021
Q1 | $1.55M | Sell |
40,208
-138,792
| -78% | -$5.25M | 0.06% | 416 |
|
|
2020
Q4 | $6.43M | Buy |
179,000
+154,745
| +638% | +$5.58M | 0.24% | 66 |
|
|
2020
Q3 | $927K | Sell |
24,255
-4,592
| -16% | -$177K | 0.06% | 461 |
|
|
2020
Q2 | $1.01M | Buy |
28,847
+2,536
| +10% | +$91.3K | 0.07% | 379 |
|
|
2020
Q1 | $859K | Buy |
+26,311
| New | +$1.03M | 0.07% | 336 |
|
|
2019
Q4 | – | Sell |
-6,253
| Closed | -$254K | – | 855 |
|
|
2019
Q3 | $254K | Buy |
+6,253
| New | +$265K | 0.02% | 612 |
|
|
2018
Q4 | – | Sell |
-5,600
| Closed | -$216K | – | 683 |
|
|
2018
Q3 | $216K | Buy |
+5,600
| New | +$196K | 0.02% | 638 |
|
|
2018
Q1 | – | Sell |
-14,786
| Closed | -$367K | – | 705 |
|
|
2017
Q4 | $367K | Buy |
+14,786
| New | +$408K | 0.05% | 365 |
|
|
2016
Q3 | – | Sell |
-14,496
| Closed | -$339K | – | 709 |
|
|
2016
Q2 | $339K | Buy |
+14,496
| New | +$314K | 0.13% | 212 |
|
|
2015
Q4 | – | Sell |
-12,800
| Closed | -$210K | – | 568 |
|
|
2015
Q3 | $210K | Buy |
+12,800
| New | +$219K | 0.1% | 303 |
|
Other funds holding BSX
VCM
VPM
Boothbay Fund Management's BSX Position: Q1 2026 in Review
Boothbay Fund Management increased its Boston Scientific (BSX) stake by 106% in Q1 2026, buying an estimated $3.1M and bringing the position to 75,212 shares worth $4.72M. The position accounts for 0.06% of the portfolio, ranked #336.
Boothbay Fund Management first reported a position in BSX in Q3 2015 and has held it in 30 quarters since. The position peaked at $16.6M in Q3 2022. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Boothbay Fund Management held 75,212 shares of Boston Scientific worth $4.72M as of Q1 2026.
- Boothbay Fund Management bought 38,768 Boston Scientific shares in Q1 2026, an estimated $3.1M.
- Boston Scientific made up 0.06% of Boothbay Fund Management's portfolio in Q1 2026, its #336 holding.
- Boothbay Fund Management first reported a position in Boston Scientific in Q3 2015 and has held it in 30 quarters since.
- Boothbay Fund Management's Boston Scientific position peaked at $16.6M in Q3 2022.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.